Literature DB >> 22325077

Antidepressant prescribing patterns among VA patients with schizophrenia.

Seth Himelhoch1, Eric Slade, Julie Kreyenbuhl, Deborah Medoff, Clayton Brown, Lisa Dixon.   

Abstract

BACKGROUND: Recent reviews have questioned the efficacy of adjuvant use of antidepressants for the treatment of depression or the treatment of primary negative symptoms among individuals with schizophrenia.
METHODS: Using administrative data from the VA's mid-Atlantic region this cross-sectional retrospective study provides estimates of receipt of prevalent and incident antidepressant medications in fiscal year 2007 (FY07) among 2412 veterans receiving treatment for schizophrenia. Multivariable logistic regression analyses were used to evaluate demographic, diagnostic and clinical characteristics associated with antidepressant receipt in FY07.
RESULTS: Approximately four out of ten (37.4%) received an antidepressant prescription of which 26.7% were incident prescriptions. SSRI or SNRI were the most common antidepressants prescribed. For both incidence and prevalence analyses, receipt of an antidepressant was significantly associated with co-occurring diagnoses of depression, PTSD, anxiety, schizoaffective disorder and receipt of care in specialty outpatient mental health clinic. Receipt of antidepressant was significantly less likely among those who were homeless compared to those who were housed. DISCUSSION: Antidepressants are commonly prescribed among veterans with schizophrenia. Antidepressant receipt was associated with the use of specialty mental health care services and with concurrent clinical diagnoses for which antidepressant medication, in the absence of schizophrenia, are commonly prescribed. Further studies are needed to examine the reasons why clinicians prescribe antidepressant medications to persons with schizophrenia and whether the benefits associated with antidepressant use outweigh their health risks. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22325077     DOI: 10.1016/j.schres.2012.01.008

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia.

Authors:  Y-T Xiang; G S Ungvari; C U Correll; H F K Chiu; N Shinfuku
Journal:  Epidemiol Psychiatr Sci       Date:  2015-08-20       Impact factor: 6.892

2.  Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.

Authors:  Arto Puranen; Marjaana Koponen; Antti Tanskanen; Jari Tiihonen; Heidi Taipale
Journal:  Eur J Clin Pharmacol       Date:  2020-01-15       Impact factor: 2.953

3.  Relationship between Antidepressant Prescription Rates and Features of Schizophrenic Patients and Its Outcome in Schizophrenia Treatment.

Authors:  Nurcan Hanci; Özlem Çetin Eker; Özlem Miraloğlu; Meral Argun Uslu; Güven Özkaya; Salih Saygın Eker
Journal:  Noro Psikiyatr Ars       Date:  2015-03-01       Impact factor: 1.339

4.  Comorbid Moderate-Severe Depressive Symptoms and their Association with Quality of Life in Chinese Patients with Schizophrenia Treated in Primary Care.

Authors:  Cai-Lan Hou; Xin-Rong Ma; Mei-Ying Cai; Yan Li; Yu Zang; Fu-Jun Jia; Yong-Qiang Lin; Helen F K Chiu; Gabor S Ungvari; Brian J Hall; Bao-Liang Zhong; Xiao-Lan Cao; Yu-Tao Xiang
Journal:  Community Ment Health J       Date:  2016-06-15

5.  Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation.

Authors:  Morten Fenger-Grøn; Claus Høstrup Vestergaard; Anette Riisgaard Ribe; Søren Paaske Johnsen; Lars Frost; Annelli Sandbæk; Dimitry S Davydow
Journal:  JAMA Netw Open       Date:  2021-05-03

Review 6.  Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia.

Authors:  Viacheslav Terevnikov; Grigori Joffe; Jan-Henry Stenberg
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-19       Impact factor: 5.176

7.  Indian Psychiatric Society multicentric study: Prescription patterns of psychotropics in India.

Authors:  Sandeep Grover; Ajit Avasthi; Vishal Sinha; Bhavesh Lakdawala; Manish Bathla; Sujata Sethi; D M Mathur; Puneet Kathuria; Sandip Shah; D Sai Baalasubramanian; Vivek Agarwal; Kamla Deka
Journal:  Indian J Psychiatry       Date:  2014-07       Impact factor: 1.759

Review 8.  Augmentation with antidepressants in schizophrenia treatment: benefit or risk.

Authors:  Ye-Meng Mao; Ming-Dao Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-16       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.